![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/csm_zurrosegroupfinal_01_70165d445d.jpg?w=860)
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
![ZUR ROSE GROUP STRENGTHENS EUROPEAN MARKET LEADERSHIP THROUGH ACQUISITION OF MAIL-ORDER AND DIABETES ACTIVITIES OF APOTAL GROUP - ACXIT Capital Partners ZUR ROSE GROUP STRENGTHENS EUROPEAN MARKET LEADERSHIP THROUGH ACQUISITION OF MAIL-ORDER AND DIABETES ACTIVITIES OF APOTAL GROUP - ACXIT Capital Partners](https://www.acxit.com/en/wp-content/uploads/2020/06/2020_06_Zur-Rose_Apotal-.jpg)
ZUR ROSE GROUP STRENGTHENS EUROPEAN MARKET LEADERSHIP THROUGH ACQUISITION OF MAIL-ORDER AND DIABETES ACTIVITIES OF APOTAL GROUP - ACXIT Capital Partners
![The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy](https://c8.alamy.com/comp/2E6JMNM/the-logo-of-swiss-based-mail-order-pharmacy-and-medical-supplier-zur-rose-group-is-seen-at-the-companys-headquarters-in-frauenfeld-switzerland-may-9-2017-reutersarnd-wiegmann-2E6JMNM.jpg)
The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy
![Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium](https://miro.medium.com/max/883/1*OsdCJ9aFtgptgdKxnurrEQ.jpeg)
Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium
![Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal | Gleiss Lutz Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal | Gleiss Lutz](https://www.gleisslutz.com/sites/default/files/gleiss_lutz_rechtanwaelte_news_healthcare_2.jpg)
Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal | Gleiss Lutz
![Apotheke Zur Rose – Im Spannungsfeld zwischen Kunden, Mitbewerbern und Politik -- Videomitschnitt der #dcomzh | Carpathia Digital Business Blog Apotheke Zur Rose – Im Spannungsfeld zwischen Kunden, Mitbewerbern und Politik -- Videomitschnitt der #dcomzh | Carpathia Digital Business Blog](https://blog.carpathia.ch/wp-content/uploads/sites/3/2020/11/eHealth-Oekosystem-Zur-Rose.jpg)